Antimalarial drug | Site | Mean Hb (sd) | p-value | |
---|---|---|---|---|
Day 0 | Day 28 | |||
AS–AQ | WRH | 8.8 (1.8) | 9.6 (1.2) | 0.015 |
NWMH | 9.6 (1.6) | 9.9 (1.2) | 0.268 | |
SMH | 10.0 (1.7) | 11.0 (1.0) | 0.008 | |
BMH | 10.3 (2.0) | 11.1 (1.6) | 0.015 | |
BGH | 10.9 (1.9) | 11.7 (1.1) | 0.006 | |
HMH | 10.1 (1.4) | 11.5 (0.9) | < 0.001 | |
TAGH | 10.5 (1.6) | 11.2 (1.2) | 0.015 | |
LEKMH | 9.9 (1.7) | 11.5 (0.8) | < 0.001 | |
EWP | 10.8 (1.4) | 12.1 (1.7) | < 0.001 | |
Overall | 10.1 (1.8) | 11.1 (1.5) | < 0.001 | |
AL | NWMH | 9.5 (1.6) | 10.6 (1.2) | 0.001 |
YMH | 9.0 (1.5) | 10.4 (1.5) | < 0.001 | |
SMH | 10.5 (1.2) | 11.3 (0.8) | 0.001 | |
BMH | 9.7 (1.3) | 10.8 (0.8) | < 0.001 | |
BGH | 10.4 (1.4) | 11.4 (1.1) | < 0.001 | |
HMH | 10.2 (1.1) | 10.9 (0.9) | 0.001 | |
TAGH | 10.9 (1.8) | 11.4 (1.4) | 0.103 | |
EWP | 10.8 (1.7) | 10.9 (1.1) | 0.693 | |
Overall | 10.1 (1.6) | 10.9 (1.2) | < 0.001 |